Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Laine

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
International Journal of Cardiology|September 28, 2016
Management and research in cancer treatment-related cardiovascular toxicity: Challenges and perspectivesJennifer Cautela, Nathalie Lalevée, Chloé Ammar, et al.
Atherosclerosis|December 27, 2019
High prevalence of mutations in perilipin 1 in patients with precocious acute coronary syndromeNathalie Bonello-Palot, Marc Laine, Thomas Cuisset, et al.
Clinical Cardiology|January 23, 2018
Early versus delayed invasive strategy for intermediate- and high-risk acute coronary syndromes managed without P2Y<sub>12</sub> receptor inhibitor pretreatment: Design and rationale of the EARLY randomized trialGilles Lemesle, Marc Laine, Mathieu Pankert, et al.
Circulation|November 22, 2017
Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related CardiotoxicityMarion Escudier, Jennifer Cautela, Nausicaa Malissen, et al.
CJC Open|November 17, 2020
Acute Coronary Syndrome in the Era of SARS-CoV-2 Infection: A Registry of the French Group of Acute Cardiac CareAthanasios Koutsoukis, Clément Delmas, François Roubille, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
International Journal of Cardiology|September 28, 2016
Management and research in cancer treatment-related cardiovascular toxicity: Challenges and perspectivesJennifer Cautela, Nathalie Lalevée, Chloé Ammar, et al.
Atherosclerosis|December 27, 2019
High prevalence of mutations in perilipin 1 in patients with precocious acute coronary syndromeNathalie Bonello-Palot, Marc Laine, Thomas Cuisset, et al.
Clinical Cardiology|January 23, 2018
Early versus delayed invasive strategy for intermediate- and high-risk acute coronary syndromes managed without P2Y<sub>12</sub> receptor inhibitor pretreatment: Design and rationale of the EARLY randomized trialGilles Lemesle, Marc Laine, Mathieu Pankert, et al.
Circulation|November 22, 2017
Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related CardiotoxicityMarion Escudier, Jennifer Cautela, Nausicaa Malissen, et al.
CJC Open|November 17, 2020
Acute Coronary Syndrome in the Era of SARS-CoV-2 Infection: A Registry of the French Group of Acute Cardiac CareAthanasios Koutsoukis, Clément Delmas, François Roubille, et al.
Pageof 9